First experience with sodium-glucose co-transporter 2 inhibitors in Polish patients with cardiovascular diseases.

Ewa DziewięckaMateusz WiniarczykMatylda GliniakMonika KaciczakSylwia Wiśniowska-ŚmiałekAleksandra KarabinowskaKatarzyna HolcmanMagdalena KostkiewiczMarta HlawatyAgata Leśniak-SobelgaPiotr PodolecPaweł Rubiś

Published in: Cardiology journal (2020)

Keyphrases

cardiovascular disease
cardiovascular risk factors
type diabetes
cardiovascular events
metabolic syndrome
coronary artery disease